Navigation Links
Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
Date:10/30/2007

sident and chief

executive officer of Gilead Sciences, Inc., has been elected to its

board of directors. Gen-Probe's board now has eight members,

including seven who are not Gen-Probe employees.

-- Update on PROCLEIX ULTRIO Post-Marketing Study. To date,

participating blood banks have screened approximately 260,000 blood

donations in the post-marketing study for the PROCLEIX ULTRIO assay,

which is designed to demonstrate hepatitis B virus (HBV) "yield."

Yield is defined as HBV-infected blood donations that were intercepted

by the PROCLEIX ULTRIO assay, but that were initially negative based

on traditional serology tests. Gen-Probe believes that the first of

two required yield cases has been identified in the study, although

this must be confirmed through a regulatory submission to the FDA.

The FDA has approved the PROCLEIX ULTRIO assay to screen donated blood

for HIV-1 and hepatitis C virus (HCV), but not to screen for HBV, as

the initial clinical studies were not designed to, and did not,

demonstrate HBV yield. Gen-Probe and Novartis are conducting the

post-marketing study to demonstrate HBV yield and gain the associated

donor screening claim.

Webcast Conference Call

A live webcast of Gen-Probe's third quarter 2007 conference call for investors can be accessed at http://www.gen-probe.com beginning at 4:30 p.m. Eastern Time today. The webcast will be archived for at least 90 days. A telephone replay of the call also will be available for approximately 24 hours. The replay number is (800) 947-6450 for domestic callers and (203) 369-3539 for international callers.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic aci
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 17, 2015 CIO Review ( http://www.cioreview.com ... 20 Most Promising Pharma and Life Science Technology Solution ... global compliance software platform for life sciences companies. ... a panel of experts and members of CIO Review’s ... MediSpend Platform has been on our radar for some ...
(Date:4/17/2015)... , April 17, 2015  Guggenheim Securities, the ... today announced the hiring of William Tanner ... Mr. Tanner will start work at Guggenheim ... York office. "Bill brings a ... research, to our experienced and highly acclaimed healthcare team," ...
(Date:4/17/2015)... 2015 Global Stem Cells Group ... Cell Summit 2015 April 27 - 29, 2015 in ... in all areas of stem cell research including applications, ... and regenerative medicine. , The conference will address ... as translational research in stem cell therapies, regenerative medicine, ...
(Date:4/17/2015)... April 17, 2015 BellBrook Labs ... marketing support for the powerful Orthogonal Pooled Screening ... Genomics Center at the Lankenau Institute for Medical ... is to measurably improve successful drug discovery outcomes ... offering rare, drug-like libraries available nowhere else, coupled ...
Breaking Biology Technology:MMIS Chosen by CIO Review as Top 20 Most Promising Pharma and Life Science Technology Solution Providers 2015 2Guggenheim Securities Hires Biotech Analyst William Tanner in Expansion of Healthcare Coverage 2Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015 2Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015 3BellBrook Labs and Lankenau Institute Partner to Accelerate Drug Discovery using Orthogonal Pooled Screening 2
... Calif., Nov. 13 AMDL, Inc. (Amex:,ADL) reported today ... Securities and,Exchange Commission indicating that its Form 10-QSB for ... filed by November 14, 2007. However,AMDL expects to file ... time,allotted by the Rules. Gary L. Dreher, President, stated: ...
... Imaging,Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS) ... announced that the Company,s,exclusive distributor in Italy, CTLM ... and other international sites at the 4th,Attualita in ... http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO ) IMDS expects Italy ...
... MEDICA is the world,s,leading medical industry trade ... November 14th-17th, to present new advances and,technologies for ... medical devices go beyond possessing Europe,s,largest market and ... government is working to enhance research and development ...
Cached Biology Technology:AMDL Announces Filing of Extension on Third Quarter 2007 Form 10-QSB 2Imaging Diagnostic Systems Exhibits CT Laser Breast Imaging Results at Major Italian Multidisciplinary Breast Cancer Meeting 2Germany Hosts World Leading Medical Industry Fair 2
(Date:3/23/2015)... 23, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, announces its biometric payment technology, the ... CNBC television starting March 30 th . ... New York markets. ... excited about our new ad campaign following the recent initial ...
(Date:3/20/2015)... , March 20, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... is one of the products featured in 2015 "I ... at 11:00 PM EST on the DIY Network.   ... Las Vegas , site of the 2015 ...
(Date:3/18/2015)... , March 18, 2015 As mobile ... new revolutionary smart wallets and apps continue to be introduced ... entrenched in the mobile payment industry in focus today are:  ... Ltd. (NYSE: BABA ), Apple Inc. (NASDAQ: ... and Facebook Inc. (NASDAQ: FB ) ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6
... the University of Kentucky have discovered that plasminogen, a protein ... up the progress of prion diseases such as mad cow ... for the development of drugs to treat prion diseases in ... researcher at the UK Sanders-Brown Center on Aging and professor ...
... - (Jan. 10, 2011) All fat cells are not ... understanding and treatment of type 2 diabetes and obesity, said ... a report that appears in the current issue of the ... The amount of fat in each cell and the central ...
... 10, 2011 Based on its recent analysis ... Sullivan recognizes Cardiocom with the 2011 North American ... provides integrated clinical telehealth services that offer significant ... (Logo:   http://photos.prnewswire.com/prnh/20081117/FSLOGO ) Cardiocom combines ...
Cached Biology News:Research identifies drug target for prion diseases, 'mad cow' 2Single cell studies identify coactivator role in fat cell maturation 2Single cell studies identify coactivator role in fat cell maturation 3Frost & Sullivan Recognizes Cardiocom as a Technology Enabler for Superior Cost-Effective Remote Chronic Care Management 2Frost & Sullivan Recognizes Cardiocom as a Technology Enabler for Superior Cost-Effective Remote Chronic Care Management 3Frost & Sullivan Recognizes Cardiocom as a Technology Enabler for Superior Cost-Effective Remote Chronic Care Management 4
... Experion HighSens reagents and supplies, ... and supplies sufficient to perform high-sensitivity ... chips on the Experion automated electrophoresis ... gel, 20 microliters RNA HighSens stain, ...
...
... BIP-NC H-IPMIK-OH Lyophilized solid. ... LIGHT. HYGROSCOPIC. PACKAGED UNDER INERT GAS. A ... V5 (Cat. No. 196810) that serves as ... apoptosis (~200 μM). Purity: ≥97% by ...
BD Falcon microtest assay plate. 1536 well 12l, black BD Optilux PS. Polystyrene, nonsterile, no lid (15/sp, 60/ca) Packaging: 15 / pack, 60 / case ...
Biology Products: